Literature DB >> 20503471

Earthworm extracts facilitate PC12 cell differentiation and promote axonal sprouting in peripheral nerve injury.

Chao-Tsung Chen1, Jaung-Geng Lin, Tung-Wu Lu, Fuu-Jen Tsai, Chih-Yang Huang, Chun-Hsu Yao, Yueh-Sheng Chen.   

Abstract

The present study provides in vitro and in vivo evaluations of earthworm (Pheretima aspergilum) on peripheral nerve regeneration. In the in vitro study, we found the earthworm (EW) water extracts caused a marked enhancement of the nerve growth factor-mediated neurite outgrowth from PC12 cells as well as the expressions of growth associated protein 43 and synapsin I. In the in vivo study, silicone rubber chambers filled with EW extracts were used to bridge a 10 mm sciatic nerve defect in rats. Eight weeks after implantation, the group receiving EW extracts had a much higher success percentage of regeneration (90%) compared to the control (60%) receiving the saline. In addition, quantitative histology of the successfully regenerated nerves revealed that myelinated axons in EW group at 31.25 microg/ml was significantly more than those in the controls (p < 0.05). These results showed that EW extracts can be a potential growth-promoting factor on regenerating peripheral nerves.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20503471     DOI: 10.1142/S0192415X10008044

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  11 in total

Review 1.  Helminthes and insects: maladies or therapies.

Authors:  Nora L El-Tantawy
Journal:  Parasitol Res       Date:  2014-12-30       Impact factor: 2.289

2.  Reproductive Injury in Male Rats from Acrylamide Toxicity and Potential Protection by Earthworm Methanolic Extract.

Authors:  Mohamed M Ahmed; Amany A Hammad; Sahar H Orabi; Hamed T Elbaz; Ahmed E Elweza; Enas A Tahoun; Mona M Elseehy; Ahmed M El-Shehawi; Ahmed A Mousa
Journal:  Animals (Basel)       Date:  2022-07-04       Impact factor: 3.231

3.  Effect of oral administration of Pheretima aspergillum (earthworm) in rats with cerebral infarction induced by middle-cerebral artery occlusion.

Authors:  Chung-Hsiang Liu; Yi-Wen Lin; Nou-Ying Tang; Hsu-Jan Liu; Chih-Yang Huang; Ching-Liang Hsieh
Journal:  Afr J Tradit Complement Altern Med       Date:  2012-10-01

4.  Epimedium extract promotes peripheral nerve regeneration in rats.

Authors:  Yuhui Kou; Zhiyong Wang; Zhihong Wu; Peixun Zhang; Yu Zhang; Xiaofeng Yin; Xisheng Wong; Guixing Qiu; Baoguo Jiang
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-17       Impact factor: 2.629

Review 5.  Origin of innate immune responses: revelation of food and medicinal applications.

Authors:  Edwin L Cooper; Kyle Hirabayashi
Journal:  J Tradit Complement Med       Date:  2013-10

6.  Dilong: food for thought and medicine.

Authors:  Edwin L Cooper; Kyle Hirabayashi; Mariappan Balamurugan
Journal:  J Tradit Complement Med       Date:  2012-10

Review 7.  Recombinant protein production of earthworm lumbrokinase for potential antithrombotic application.

Authors:  Kevin Yueju Wang; Lauren Tull; Edwin Cooper; Nan Wang; Dehu Liu
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-12       Impact factor: 2.629

8.  Earthworm (Pheretima aspergillum) extract stimulates osteoblast activity and inhibits osteoclast differentiation.

Authors:  Yuan-Tsung Fu; Kuo-Yu Chen; Yueh-Sheng Chen; Chun-Hsu Yao
Journal:  BMC Complement Altern Med       Date:  2014-11-11       Impact factor: 3.659

9.  Local administration of icariin contributes to peripheral nerve regeneration and functional recovery.

Authors:  Bo Chen; Su-Ping Niu; Zhi-Yong Wang; Zhen-Wei Wang; Jiu-Xu Deng; Pei-Xun Zhang; Xiao-Feng Yin; Na Han; Yu-Hui Kou; Bao-Guo Jiang
Journal:  Neural Regen Res       Date:  2015-01       Impact factor: 5.135

10.  Earthworms dilong: ancient, inexpensive, noncontroversial models may help clarify approaches to integrated medicine emphasizing neuroimmune systems.

Authors:  Edwin L Cooper; Mariappan Balamurugan; Chih-Yang Huang; Clara R Tsao; Jesus Heredia; Mila Tommaseo-Ponzetta; Maurizio G Paoletti
Journal:  Evid Based Complement Alternat Med       Date:  2012-07-25       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.